Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) today announced significant progress in three HCV programs. Idenix will provide a business update on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE